ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,970,024 | -31.3% | 3,254,353 | -3.5% | 0.04% | -25.9% |
| Q2 2023 | $21,796,394 | -0.5% | 3,374,055 | +16.2% | 0.05% | -1.8% |
| Q1 2023 | $21,898,113 | -14.3% | 2,904,259 | +15.1% | 0.06% | -22.5% |
| Q4 2022 | $25,551,122 | +22.8% | 2,522,322 | +19.9% | 0.07% | +16.4% |
| Q3 2022 | $20,809,000 | +12.5% | 2,104,041 | +21.2% | 0.06% | +22.0% |
| Q2 2022 | $18,491,000 | +47.2% | 1,736,219 | +34.8% | 0.05% | +78.6% |
| Q1 2022 | $12,558,000 | +6.1% | 1,288,000 | +55.6% | 0.03% | +27.3% |
| Q4 2021 | $11,838,000 | +0.1% | 827,847 | +40.3% | 0.02% | -4.3% |
| Q3 2021 | $11,824,000 | +35.7% | 590,000 | +49.0% | 0.02% | +43.8% |
| Q2 2021 | $8,712,000 | +413.1% | 396,000 | +692.0% | 0.02% | +433.3% |
| Q1 2021 | $1,698,000 | -15.6% | 50,000 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $2,012,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |